A study to determine if BHV-2100 and BHV-7000 are effective, safe, and tolerable as a pain medication in healthy male participants
This study is investigating two experimental pain relief medications, BHV-2100 and BHV-7000, in healthy adult men. The main goal is to find out if these medications are effective at reducing pain, how safe they are to use, and if people can tolerate them well. This is an early-stage study, meaning it's one of the first times these specific drugs are being tested in humans. By carefully studying these medications, researchers hope to gather important information that could lead to new and improved ways to treat pain in the future, ultimately benefiting many people.
At a glance
What is this study about?
Imagine you have a headache, or a sprained ankle – pain is something most of us experience at some point. While there are many pain relief medicines available, doctors and researchers are always looking for new and improved options that might work better, have fewer side effects, or help people who don't get enough relief from current treatments. This study is an important step in that process.
Researchers are focusing on two new medications, called BHV-2100 and BHV-7000. They want to understand a few key things: firstly, if these medications can actually help with pain; secondly, if they are safe to use, meaning they don't cause too many unwanted side effects; and thirdly, if people can take them without feeling too unwell. This is an early-stage study, specifically designed to gather initial information about these drugs in people for the first time.
By carefully testing these new medications in healthy male volunteers, scientists can learn a lot about how the drugs work in the body. This information is absolutely vital. If these early studies show promise, it could pave the way for bigger studies in the future, eventually leading to new pain relief options being available to a wider group of people who need them. It's all about making sure new medicines are both effective and safe.
Key takeaways
- This study is testing two new pain medications in healthy men.
- It aims to check if the medications are effective, safe, and easily tolerated.
- It's an early-stage study to gather initial information about the drugs.
- Participation could help develop future pain treatments.
- You will be closely monitored for your safety and well-being.
Who may be eligible?
To be considered for this study, you must be a healthy man, aged 18 years or older. There is no upper age limit, meaning men of any age beyond 18 years can potentially take part. Being 'healthy' usually means you don't have any significant ongoing medical conditions that could interfere with the study or make taking the medication unsafe for you.
It's important to remember that this study is specifically looking for men. Women cannot take part in this particular trial. Also, if you have certain health problems, even if they aren't directly related to pain, you might not be suitable for the study. For example, conditions affecting your heart, liver, or kidneys could prevent you from participating, as these organs are important in processing medicines.
The research team will carry out several checks and ask you detailed questions about your health and medical history before you can join. This is to make sure the study is as safe as possible for everyone involved and that the results they get are clear and reliable.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you a man?
- Are you 18 years old or older?
- Do you consider yourself generally healthy?
- Are you able to attend appointments at the study clinic?
What does participation involve?
If you decide to take part in this study, you would receive either the new experimental pain medication (BHV-2100 or BHV-7000) or a dummy pill (placebo). The study will likely involve several visits to a clinic over a set period. During these visits, the research team will ask you questions about how you are feeling and any pain you might experience. They will also perform various assessments, which might include blood tests, checking your heart rate and blood pressure, and other routine health checks to monitor your safety and see how your body is reacting to the medication.
Specific details about the number of visits, how long each visit lasts, and the total duration you would be involved in the study (including any follow-up appointments after you stop taking the medication) would be explained thoroughly by the study team. You would also be told exactly how the medication is given (e.g., as a tablet, or injection) and how often you need to take it.
Potential risks and benefits
Locations (1)
- —UnverifiedGermany
Common questions
What kind of pain will be treated in this study?
This early-stage study in healthy volunteers isn't focused on treating a specific type of pain. It's about understanding how the new medications work generally and if they are safe.
Will I definitely receive one of the new medications?
You might receive one of the new medications (BHV-2100 or BHV-7000) or a placebo (a dummy pill with no active drug) to help compare the effects. You won't know which you are receiving.
How long will I need to be in the study?
The exact duration of your involvement will be thoroughly explained by the study team before you agree to take part. It varies depending on the specific study design.
Will I be paid to take part?
Some studies, especially those involving healthy volunteers, offer compensation for your time and travel. This will be discussed with you by the research team if applicable.
Can I change my mind after joining the study?
Yes, you are always free to withdraw from the study at any point, for any reason, without it affecting your usual medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.